Preoperative low dose continuous infusion of 5-fluorouracil (5-FU) with cisplatin for potentially unresectable advanced gastric cancer (AGC) with extensive lymph node metastasis: a phase II study

被引：0
|
作者：
Chin, KC [1 ]
Imazu, HI [1 ]
Mochiki, EM [1 ]
Tokunaga, AT [1 ]
Hosoya, YH [1 ]
Tsujitani, ST [1 ]
Nakajima, TN [1 ]
机构：
[1] Exploratory Chemotherapy Trial Grp Gastr Canc Jap, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF CANCER | 2002年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：251 / 252
页数：2
相关论文
共 50 条
  • [1] Phase I Irinotecan, Cisplatin and protracted infusion 5-FU (ICF) in advanced gastric cancer (AGC)
    Fernandez Martos, Carlos
    Segura, Angel
    Aparicio, Jorge
    Molins, Carmen
    Busquier, Isabel
    Poveda, Andres
    Balcells, Miquel
    ANNALS OF ONCOLOGY, 2004, 15 : 238 - 238
  • [2] Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma
    Chung, YS
    Yamashita, Y
    Inoue, T
    Matsuoka, T
    Nakata, B
    Onoda, N
    Maeda, K
    Sawada, T
    Kato, Y
    Shirasaka, T
    Sowa, M
    CANCER, 1997, 80 (01) : 1 - 7
  • [3] The efficacy and safety of combination chemotherapy with paclitaxel, 5-fluorouracil (5-FU) and cisplatin for advanced gastric carcinoma: A phase II study
    Kim, S.
    Lim, H.
    Lee, H.
    Yuh, Y.
    ANNALS OF ONCOLOGY, 2007, 18 : VII54 - VII55
  • [4] Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
    Bleiberg, H
    Conroy, T
    Paillot, B
    Lacave, AJ
    Blijham, G
    Jacob, JH
    Bedenne, L
    Namer, M
    DeBesi, P
    Gay, F
    Collette, L
    Sahmoud, T
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1216 - 1220
  • [5] Phase II trials of pancreatic and hepatic arterial infusion of 5-fluorouracil (5-FU) and cisplatin (CDOP) in patients with advanced pancreatic cancer with or without liver metastasis
    Denno, R
    Sasada, T
    Kanai, M
    Takabayashi, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 348S - 348S
  • [6] Paclitaxel (T) plus 5-fluorouraciL (5-FU): A novel and very active regimen for advanced gastric cancer (AGC). A phase II trial
    Murad, AM
    Guimaraes, RC
    Aragao, BC
    Ferreira, AF
    Schwartsmann, G
    Brundani, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1255 - 1255
  • [7] Docetaxel and 5-FU continuous infusion (DF) versus epirubicin, cisplatin and 5-FU (ECF) for advanced gastric adenocarcinoma:: A randomised phase II study.
    Thuss-Patience, PC
    Kretzschmar, A
    Vielhaber, A
    Dörken, B
    Reichardt, P
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [8] Feasibility of preoperative radiotherapy with weekly oxaliplatin (OXA), 5-fluorouracil (5-FU) continuous infusion in the treatment of locally advanced rectal cancer: Phase I study
    Friso, ML
    Aschele, C
    Pucciarelli, S
    Fabris, G
    Martella, B
    Munegato, M
    Ranzato, R
    Neri, D
    Fasano, C
    Lora, O
    Loreggian, L
    Toppan, P
    Muzzio, PC
    Sotti, G
    TUMORI, 2001, 87 (04) : S109 - S109
  • [9] A phase II trial of paclitaxel, cisplatin, and weekly 24 h infusion of 5-Fluorouracil (5-FU)/folinic acid (FA) in patients (pts) with advanced gastric cancer
    Kollmannsberger, C
    Quietzch, D
    Clemens, M
    Lampe, C
    Lingenfelser, T
    Hartmann, JT
    Kanz, L
    Bokemeyer, C
    ANNALS OF ONCOLOGY, 1998, 9 : 48 - 48
  • [10] Weekly high-dose 5-fluorouracil (5-FU), leucovorin (LV) and bimonthly cisplatin in patients with advanced gastric cancer
    Lin, YC
    Chen, JS
    Wang, CH
    Wang, HM
    Chang, HK
    Liau, CT
    Yang, TS
    Liaw, CC
    Liu, HE
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (12) : 605 - 609
12345